Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-21-138
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.393 Cancer Cause and Prevention Research
- 93.394 Cancer Detection and Diagnosis Research
- 93.395 Cancer Treatment Research
- 93.396 Cancer Biology Research
- 93.397 Cancer Centers Support Grants
- 93.399 Cancer Control
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- City/Township Governments
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Public)
- Other
- Independent School Districts
- Public or Indian Housing Auth.
- 501(c)(3) Nonprofits
- County Governments
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- Small Businesses
- For Profit Organizations
- Special District Governments
- Non-501(c)(3) Nonprofits
- State Governments
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:
Files
| File | Type | Posted |
|---|---|---|
| PAR-21-138-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity